Japan's Groundbreaking Achievement: 100% Pure mRNA Production Revolutionizes Vaccines

A research team from Japan has developed a method called 'Purecap' to produce highly pure mRNA vaccines, which could lead to more effective vaccines with lower chances of inflammation. The technique involves using a unique cap structure to easily separate the desired capped mRNA, resulting in up to 100% pure Cap2-type mRNA. This pure mRNA showed 3-4 times better production of the immune-stimulating protein. The findings open up the possibility of purer vaccines with reduced risk of inflammation caused by impurities. The technique has the potential to improve the safety and efficacy of mRNA vaccines and advance the practical application of mRNA medicine.